Humalog Kwikpen U200

How is this medication used?

Before using Humalog KwikPen U-200, read the patient information leaflet provided by your pharmacist. This medication is injected under the skin (subcutaneously) usually within 15 minutes before or right after meals. Dosage is based on your medical condition and response to treatment. It is important to rotate injection sites with each dose to avoid skin damage. Check your insulin product visually for particles or discoloration before use. If either is present, do not use the insulin.

What are the possible side effects?

Common side effects include low blood sugar (hypoglycemia), reaction at the injection site (such as pain, redness, or irritation), and weight gain. Hypoglycemia is a serious side effect and can cause symptoms such as shaking, fast heartbeat, hunger, blurred vision, dizziness, or tingling hands/feet. It is crucial to have a source of sugar available at all times to counteract low blood sugar. Severe allergic reactions are rare but seek immediate medical attention if you notice symptoms such as rash, itching/swelling, severe dizziness, or trouble breathing.

What are the potential interactions?

Many drugs can affect your blood sugar, making it harder to control. Before starting Humalog KwikPen U-200, tell your doctor about all your current medications, especially ones that decrease blood sugar (such as alpha or beta blockers, ACE inhibitors, or steroids). Alcohol, beta-blockers, and some other medications may also intensify the hypoglycemic effect of insulin. It is important to check blood sugar levels regularly and consult with your healthcare provider to adjust the dose as necessary.

Disclaimer: The information provided on this website is for informational purposes only and is not intended as medical advice. Always consult with your healthcare provider for medical advice, diagnosis, or treatment. Images are for representation purposes only and actual packing may differ by brand and/or manufacturer.